LA Private

July 28, 2023

Fed & ECB at/near top, BoJ tweaks yield control, Aust inf falling, RBA to hold but a close call

Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and Australia economic events. Investment markets and key developments over the past week Global shares were mixed over the last week being buoyed by increasing confidence that […]

Fed & ECB at/near top, BoJ tweaks yield control, Aust inf falling, RBA to hold but a close call Read More »

Stocks of the Hour: Immutep, Pointerra, Zeus Resources

First Patient Dosed in Chemotherapy-Free Triple Combination Phase II Trial Targeting Soft Tissue Sarcoma Immutep (ASX:IMM; NASDAQ:IMMP) announced that the first patient has been dosed in the Chemotherapy-free Combination Phase II Trial Targeting Sarcoma, a disease in which malignant (cancer) cells form in the soft tissues of the body. In response, Immutep CSO, Frédéric Triebe

Stocks of the Hour: Immutep, Pointerra, Zeus Resources Read More »

Japan and South Korea decline offer to join $44 billion LNG project

Japan and South Korea have rejected US overtures to join the proposed $44 billion Alaska natural-gas project, which could be one of the most significant energy investments in American history. The project, known as Alaska LNG, involves an 807-mile pipeline transporting natural gas from fields north of the Arctic Circle to the southern part of

Japan and South Korea decline offer to join $44 billion LNG project Read More »